JC

James Calloway

Financial Reporter

James Calloway is a financial reporter at StockTi covering corporate earnings, regulatory policy, and market-moving events. A former business journalist with Reuters, James has covered financial markets for over eight years across New York and Washington. He specializes in breaking down earnings reports, SEC filings, and policy decisions that affect publicly traded companies and investor portfolios.

Earnings, Regulation 1,769 articles

Articles by James Calloway

Sysco Shares Dip 3.6% on Sales Miss as Restaurant Demand Weighs on $29B Deal
Earnings

Sysco Shares Dip 3.6% on Sales Miss as Restaurant Demand Weighs on $29B Deal

Sysco shares dropped 3.6% after quarterly sales missed estimates, reflecting sluggish restaurant demand. The company reaffirmed its full-year outlook and highlighted local restaurant sales growth.

SYY
BigBear.ai Shares Surge Ahead of Q1 Earnings Amid Key 2026 Test
Earnings

BigBear.ai Shares Surge Ahead of Q1 Earnings Amid Key 2026 Test

BigBear.ai shares rose 8% to $4.03 ahead of Q1 earnings due May 5, with trading volume near 50.5 million. Investors eye the $250 million Ask Sage acquisition and revenue guidance.

BBAI PLTR AI
Navitas Shares Tumble 17% as AI Power Chip Rally Faces Earnings Scrutiny
Earnings

Navitas Shares Tumble 17% as AI Power Chip Rally Faces Earnings Scrutiny

Navitas Semiconductor shares dropped 17% on Tuesday as the AI power chip rally hit an earnings test. Analysts expect a Q1 loss of $0.05 per share on $8.18 million revenue.

NVTS
Zimmer Biomet Stock Falls 9% Despite Earnings Beat and Raised Forecast
Earnings

Zimmer Biomet Stock Falls 9% Despite Earnings Beat and Raised Forecast

Zimmer Biomet shares dropped 9% Tuesday after beating Q1 estimates and raising its 2026 profit forecast, as investors focused on an unchanged sales outlook and the CFO's exit.

ZBH
Omnicell Shares Jump 17.5% on Q1 Beat, Raised 2026 Guidance
Earnings

Omnicell Shares Jump 17.5% on Q1 Beat, Raised 2026 Guidance

Omnicell shares jumped 17.5% after Q1 results topped estimates and the company raised its 2026 profit outlook, citing strong demand for its Titan XT system.

OMCL
Centene Lifts 2026 Forecast After Q1 Earnings Beat on Medical Costs
Earnings

Centene Lifts 2026 Forecast After Q1 Earnings Beat on Medical Costs

Centene raised its 2026 profit outlook after Q1 earnings beat estimates, citing better medical cost management. Shares jumped over 6%.

CNC
Microsoft Shares Steady Ahead of Azure Earnings Test
Earnings

Microsoft Shares Steady Ahead of Azure Earnings Test

Microsoft shares edged up 0.3% to $426.14 Tuesday as investors await fiscal third-quarter earnings. Azure revenue is expected to rise about 40%.

MSFT AMZN GOOGL META
Amazon Shares Dip Ahead of Q1 Earnings as AI Spending Scrutiny Intensifies
Earnings

Amazon Shares Dip Ahead of Q1 Earnings as AI Spending Scrutiny Intensifies

Amazon shares edged lower Tuesday as the market braces for first-quarter results that will test whether AWS growth can justify the company's heavy AI infrastructure investments.

AMZN GOOGL MSFT META ORCL
Ulta Beauty Shares Dip as Investors Eye AI Strategy Impact
Earnings

Ulta Beauty Shares Dip as Investors Eye AI Strategy Impact

Ulta Beauty shares continued their slide Tuesday as the market weighs the retailer's AI push and 2026 outlook. The stock is down 24.5% from its February peak.

ULTA
American Tower Lifts 2026 Guidance After Strong Q1 Results
Earnings

American Tower Lifts 2026 Guidance After Strong Q1 Results

American Tower raised its 2026 forecast after Q1 revenue rose 6.8% to $2.74 billion and net income surged 76.2%, both topping estimates. Shares gained 1.9%.

Celestica Stock Tumbles Despite AI Demand Surge and Upgraded Forecast
Earnings

Celestica Stock Tumbles Despite AI Demand Surge and Upgraded Forecast

Celestica raised its 2026 revenue forecast to $19B after a strong Q1, yet shares fell 15% as market expectations outpace growth.

CLS
Apple Stock Edges Up Ahead of Earnings; UBS Highlights iPhone Gains
Earnings

Apple Stock Edges Up Ahead of Earnings; UBS Highlights iPhone Gains

Apple shares gained 1.1% to $270.59 on Tuesday ahead of earnings, as UBS lifted its price target to $287 on iPhone strength. The report is the first since the CEO transition announcement.

AAPL